Skip to main content
logo
Janux Therapeutics, Inc. (JANX)
NASDAQ: JANX · Real-Time Price · USD
14.52
+0.11 (0.76%)
At close: May 22, 2026, 4:00 PM EDT
14.51
-0.01 (-0.07%)
After-hours: May 22, 2026, 5:47 PM EDT

Janux Therapeutics Revenue

Janux Therapeutics had revenue of $3.73M in the quarter ending March 31, 2026. This brings the company's revenue in the last twelve months to $13.73M, up 47.10% year-over-year. In the year 2025, Janux Therapeutics had annual revenue of $10.00M, down -5.55%.

Revenue (ttm)
$13.73M
Revenue Growth
+47.10%
P/S Ratio
64.48
Revenue / Employee
$127,157
Employees
108
Market Cap
885.49M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202510.00M-588.00K-5.55%
Dec 31, 202410.59M2.51M30.99%
Dec 31, 20238.08M-529.00K-6.14%
Dec 31, 20228.61M4.98M136.79%
Dec 31, 20213.64M--
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Pharming Group369.49M
Phathom Pharmaceuticals204.89M
Arbutus Biopharma191.45M
Theravance Biopharma109.78M
MeiraGTx Holdings79.76M
Revenue Rankings

JANX News

More News